Hinge Health announced the launch of its initial public offering of Class A common stock. The company filed a registration statement with the U.S. Securities and Exchange Commission to offer a total of 13,666,000 shares, with 8,522,528 offered by Hinge Health and 5,143,472 by certain selling stockholders. The selling stockholders may also grant underwriters a 30-day option to purchase up to an additional 2,049,900 shares. The expected IPO price range is between $28.00 and $32.00 per share. The offering will be led by Morgan Stanley, Barclays, and BofA Securities, with several other firms serving as book-running managers.
Hinge Health plans to use the proceeds it receives to meet tax obligations related to the issuance of shares from restricted stock units. The company will not receive any proceeds from shares sold by the selling stockholders. The registration statement has been filed but is not yet effective. Based in musculoskeletal (MSK) care, Hinge Health provides a digital platform that uses software, including AI, to support joint and muscle treatment, offering care for conditions ranging from injuries to post-surgical rehabilitation.
